Intrinsic Value

BioCryst Pharmaceuticals, Inc. (BCRX)


-0.04 (-0.47%)

Enterprise Value -2,149,003.29
Net Debt 436.69
Equity Value -2,149,439.97
Shares Outstanding 179.12
Equity Value Per Share -12,000.20

Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt